Tag: chronic kidney disease market outlook

Uncover key drivers, emerging technologies, and competitive movements shaping the chronic kidney disease market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Chronic Kidney Disease Market size between 2026 and 2035?

The market size for chronic kidney disease has witnessed substantial growth in recent years. It is anticipated to expand from $74.87 billion in 2025 to $79.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. Historical growth can be attributed to the rising incidence of diabetes and hypertension, enhanced accessibility to dialysis infrastructure, advancements in kidney function diagnostics, increased understanding of chronic renal disorders, and the expansion of nephrology care services.

The chronic kidney disease market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $101.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. Several factors are expected to fuel this growth during the forecast period, including the accelerated development of innovative renal treatments, a heightened demand for patient-focused dialysis solutions, the spread of digital monitoring for kidney health, an increased emphasis on preparing for transplants, and greater financial commitments to preventive nephrology. Key trends anticipated during this period encompass a stronger focus on identifying chronic kidney disease early, the increasing uptake of medications designed to protect kidney function, a broader implementation of home-based dialysis methods, the growth of integrated care approaches involving multiple specialties, and a concentrated effort to decelerate the disease’s advancement.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

Which Drivers Are Impacting Market Performance In The Chronic Kidney Disease Market?

The rising occurrence of kidney disease is anticipated to drive the expansion of the chronic kidney disease market in the future. These diseases encompass various conditions that impair the kidneys’ structure and ability to function. Therapeutics for kidney disease are administered to regulate patient blood pressure and reduce protein leakage, thereby slowing the advancement of kidney damage, alleviating symptoms, and preventing complications. For instance, in June 2023, Kidney Research UK, a UK-based, charity dedicated to funding research into kidney disease, reported that by 2033, the population affected by CKD stages 3–5 is expected to rise to around 3.9 million. Consequently, the growing incidence of kidney disease is fueling the expansion of the chronic kidney disease market.

Which Segments Are Contributing To The Growth Of The Chronic Kidney Disease Market?

The chronic kidney disease market covered in this report is segmented –

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-Ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Long-Term Trends Are Expected To Shape The Future Of The Chronic Kidney Disease Market?

Leading firms operating in the chronic kidney disease market are adopting strategic partnerships to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. Such strategic partnerships entail a process where companies leverage each other’s strengths and resources to achieve mutual benefits and success. As an illustration, in June 2023, AWAK Technologies Pte Ltd., a Singapore-based medical technology company, collaborated with Singapore General Hospital Pte Ltd. (SGH), a Singapore-based academic health science center and hospital company. Through this partnership, they intend to revolutionize the diagnosis, treatment, and management of kidney disease, which includes the development and testing of a wearable and ultra-portable peritoneal dialysis (PD) system, known as AWAK PD, enabling patients with end-stage kidney disease to undergo dialysis at home and on the go.

Who Are The Core Companies Influencing Trends In The Chronic Kidney Disease Market?

Major companies operating in the chronic kidney disease market are Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Chronic Kidney Disease Market?

North America was the largest region in the chronic kidney disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chronic Kidney Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

Browse Through More Reports Similar to the Global Chronic Kidney Disease Market 2026, By The Business Research Company

Late Stage Chronic Kidney Disease Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report

Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Diabetic Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Chronic Kidney Disease Market?

The chronic kidney disease market has shown significant expansion in recent years. Its value is expected to increase from $70.65 billion in 2024 to $74.87 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.0%. This past growth can be attributed to the hypertension and diabetes epidemic, an aging population, unhealthy lifestyles, healthcare access disparities, and medical advances.

The chronic kidney disease market is poised for significant expansion in the upcoming years. It is forecast to achieve a size of $95.43 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.3%. This expected increase during the forecast period stems from factors such as a strong emphasis on healthcare policies, progress in precision medicine, an uptick in obesity rates, the spread of chronic diseases, and better access to healthcare. Notable trends influencing this period include early screening campaigns, the adoption of telemedicine and remote monitoring, patient empowerment initiatives, local community-based care programs, and the integration of nutritional therapy.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

Which Major Market Drivers Are Shaping The Future Of The Chronic Kidney Disease Market?

The growing occurrence of kidney disease is projected to stimulate the chronic kidney disease market’s future expansion. Kidney diseases are defined as a range of conditions that impair the kidneys’ function and structure. Treatments for kidney disease aim to regulate patient blood pressure and lessen protein loss to prevent further kidney damage, alleviate symptoms, and avert complications. For example, in July 2022, the Centers for Disease Control and Prevention, a US-based national public health agency, reported that about 15%, or 37 million people in the US, were living with kidney disease. As a result, the increasing prevalence of kidney disease is propelling the growth of the chronic kidney disease market.

How Is The Chronic Kidney Disease Market Classified Into Different Segments?

The chronic kidney diseasemarket covered in this report is segmented –

1) By Diagnosis: Blood Test; Urine Test; Imaging Test; Kidney Biopsy

2) By Treatment: Drugs; Dialysis; Kidney Transplant; ACE Inhibitors; Blood Test; Other Treatments

3) By Route of Administration: Oral; Intravenous; Subcutaneous

4) By End-User: Hospital And Clinics; Ambulatory Surgery Centers (ASCs); Dialysis Centers; Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test; Glomerular Filtration Rate (GFR) Test; Blood Urea Nitrogen (BUN) Test; Electrolyte Tests

2) By Urine Test: Urinalysis; 24-hour Urine Collection; Urine Protein Test; Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound; CT Scan; MRI; X-ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy; Open Kidney Biopsy; Laparoscopic Kidney Biopsy

What Are The Major Trends Driving The Growth Of The Chronic Kidney Disease Market?

Product innovation represents a significant and increasingly popular trend within the chronic kidney disease market. Companies operating in the chronic kidney disease market are focused on developing innovative products to maintain their standing. For example, in August 2022, Bayer, a Germany-based biotechnology and pharmaceutical company, released the innovative medicine Kerendia (finerenone) with the aim of slowing the progression of chronic kidney disease in diabetes patients. This medication is a pioneering non-steroidal, selective mineralocorticoid receptor antagonist, differing from currently available treatments. It works by inhibiting the overactivation of mineralocorticoid receptors (MR), which contributes to the advancement of CKD and cardiovascular damage.

Which Leading Players Are Enhancing Their Chronic Kidney Disease Market Presence Worldwide?

Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Chronic Kidney Disease Market?

North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chronic Kidney Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

Browse Through More Reports Similar to the Global Chronic Kidney Disease Market 2025, By The Business Research Company

Polymerase Chain Reactions Devices Reagents And Uses Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

Waterbased Adhesives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/waterbased-adhesives-global-market-report

Ethylene Propylene Epdm Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ethylene-propylene-epdm-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Chronic Kidney Disease Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for chronic kidney disease has seen impressive growth in the recent past. It is projected to increase from $70.65 billion in 2024 to $74.87 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.0%. The historical growth surge can be ascribed to factors such as the escalating epidemic of hypertension and diabetes, an aging demographic, unhealthy living habits, unevenness in healthcare accessibility, and advancements in medicine.

Expectations suggest that the market size for chronic kidney disease will experience substantial growth in the upcoming years, reaching an estimated value of$95.43 billion by 2029″ with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to this predicted growth during the forecast period include a heightened focus on healthcare policies, advancements in precision medicine, an increase in obesity rates, the proliferation of chronic diseases, and enhanced access to healthcare. Important trends expected to emerge during the forecast period encompass initiatives for early disease screening, the use of telemedicine and remote monitoring, patient empowerment schemes, care programs rooted in the community, and the incorporation of nutritional therapy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

Which Primay Drivers Are Accelerating Growth in the Chronic Kidney Disease Market?

The escalating incidence of kidney ailments is anticipated to boost the expansion of the chronic kidney disease market in the future. Kidney diseases encompass a variety of conditions impacting the kidneys’ function and structure. Medication for kidney disease aims to manage patients’ blood pressure and reduce protein loss, hence delaying kidney deterioration, managing symptoms, and preventing complications. For example, as per the Centers for Disease Control and Prevention, a national public health agency in the US, in July 2022, about 15%, equivalent to 37 million people, across the US, suffered from kidney disease. Consequently, the escalating incidence of kidney disease is spurring the expansion of the chronic kidney disease market.

Which Primary Segments of the Chronic Kidney Disease Market Are Driving Growth and Industry Transformations?

The chronic kidney diseasemarket covered in this report is segmented –

1) By Diagnosis: Blood Test; Urine Test; Imaging Test; Kidney Biopsy

2) By Treatment: Drugs; Dialysis; Kidney Transplant; ACE Inhibitors; Blood Test; Other Treatments

3) By Route of Administration: Oral; Intravenous; Subcutaneous

4) By End-User: Hospital And Clinics; Ambulatory Surgery Centers (ASCs); Dialysis Centers; Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test; Glomerular Filtration Rate (GFR) Test; Blood Urea Nitrogen (BUN) Test; Electrolyte Tests

2) By Urine Test: Urinalysis; 24-hour Urine Collection; Urine Protein Test; Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound; CT Scan; MRI; X-ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy; Open Kidney Biopsy; Laparoscopic Kidney Biopsy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Chronic Kidney Disease Market?# Market?

North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Chronic Kidney Disease Industry Dynamics?

In the chronic kidney disease marketplace, product innovations are emerging as a leading trend. Firms active in the sector are introducing inventive products to maintain their market presence. For example, Bayer, a German biotech and pharma firm, introduced the trailblazing medicine Kerendia (finerenone) in August 2022. This is designed to decelerate chronic kidney disease in diabetes patients, setting it apart from present treatment options. It operates as a first-of-its-kind non-steroidal, selective mineralocorticoid receptor antagonist, targeting mineralocorticoid receptor (MR) overactivation which contributes to both CKD progression and cardiovascular harm.

View the full report here:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

What Parameters Are Used to Define the Chronic Kidney Disease Market?

Chronic kidney disease is characterized by the inability of damaged kidneys to efficiently filter blood, resulting in excess fluid and blood waste in the body, potentially leading to health problems. It is commonly caused by diabetes, high blood pressure, and obesity. It requires careful, ongoing management and has the potential to proceed to end-stage renal failure requiring dialysis or transplant.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11969

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Chronic Kidney Disease Market Growth in 2025?

The market size for chronic kidney disease has seen a formidable growth in the latter years. The escalation is projected to go from $70.65 billion in 2024 to $75.09 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.3%. Factors fuelling this growth rate during the historical timeframe include the rise in hypertension and diabetes, an aging demographic, unhealthy lifestyle habits, healthcare accessibility issues and advances made in the medical field.

What Is the Forecast for the Chronic Kidney Disease Market Size Through 2029?

The market size of chronic kidney disease is anticipated to experience robust growth in the coming years, reaching $95.85 billion by 2029 with a compound annual growth rate (CAGR) of 6.3%. This expected growth within the forecasted period can be related to healthcare policy priorities, advancements in precision medicine, an increasing obesity rate, rise in chronic diseases, and better healthcare accessibility. Major future trends entail early detection campaigns, telemedicine and remote patient monitoring, patient strengthening programs, community-centric care efforts, and the incorporation of nutritional therapy.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

What are the Key Market Players in Chronic Kidney Disease Market and How They’re Evolving?

Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

What Are the Primary Growth Drivers in the Chronic Kidney Disease Market?

The surge in kidney disease cases is poised to bolster the expansion of the chronic kidney disease market. Encompassing a variety of conditions impacting the kidneys’ operation and structure, kidney diseases necessitate medication for controlling patients’ blood pressure and reducing protein loss. This is done in order to inhibit kidney deterioration, handle symptoms, and prevent side effects. As per the Centers for Disease Control and Prevention, a national public health agency in the US, it was reported that in July 2022, around 15%, or 37 million US citizens, suffered from kidney disease. As a result, the escalating incidence of kidney disease is fuelling the expansion of the chronic kidney disease market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

What Are the Leading Segments in the Global Chronic Kidney Disease Industry?

The chronic kidney disease market covered in this report is segmented –

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Are the Key Market Trends in the Chronic Kidney Disease Industry?

A key trend that’s gaining traction in the chronic kidney disease market is the innovation of products. To maintain their market stature, companies in this arena are creating inventive products. For example, Bayer, a biotechnology and pharmaceutical firm based in Germany, unveiled the innovative medication Kerendia (finerenone) in August 2022. This new drug is designed to slow down the progression of chronic kidney disease among diabetic patients. It stands out as a first-of-its-kind non-steroidal, selective mineralocorticoid receptor antagonist that is distinct from current treatments. Its main function is to block overactivation of the mineralocorticoid receptor (MR), which plays a key role in advancing CKD and causing cardiovascular damage.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

What Is the Regional Outlook for the Chronic Kidney Disease Market?

North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11969

This Report Delivers Insight On:

1. How big is the chronic kidney disease market, and how is it changing globally?

2. Who are the major companies in the chronic kidney disease market, and how are they performing?

3. What are the key opportunities and risks in the chronic kidney disease market right now?

4. Which products or customer segments are growing the most in the chronic kidney disease market?

5. What factors are helping or slowing down the growth of the chronic kidney disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the chronic kidney disease industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has the Chronic Kidney Disease Market Growth Performance Trended Historically, And What Lies Ahead?

Recent years have witnessed substantial growth in the chronic kidney disease market size. It is estimated to increase from $70.65 billion in 2024 to $75.09 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.3%. Factors contributing to the growth during the historic period include the epidemic of hypertension and diabetes, an aging population, unhealthy lifestyles, disparities in access to healthcare, and advancements in medical technologies.

The market for chronic kidney disease is anticipated to undergo substantial growth in the upcoming years, reaching a value of $95.85 billion in 2029 with a compound annual growth rate (CAGR) of 6.3%. This projected growth can be linked to factors such as a focus on healthcare policies, advancements in precision medicine, escalating obesity rates, a surge in chronic diseases, and enhanced healthcare accessibility. Predominant trends expected during the forecast period encompass initiatives for early screening, telemedicine and remote monitoring, initiatives for patient empowerment, community-centered care programs, and the inclusion of nutritional therapy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theChronic Kidney Disease Market?

The escalating incidence of kidney disorders is anticipated to fuel the expansion of the chronic kidney disease market in the future. Kidney maladies are a spectrum of diseases impacting the kidneys’ functionality and arrangement. Kidney disease medication is employed to regulate blood pressure and minimize protein loss in patients, preventing further kidney degeneration, managing symptoms, and averting ramifications. For example, as per the Centers for Disease Control and Prevention, a public health agency based in the US, around 15% or 37 million people in the US were suffering from some form of kidney disease as of July 2022. Consequently, the mounting incidence of kidney disease is stimulating the growth of the chronic kidney disease market.

Which Segments in the Chronic Kidney Disease Offer the Most Growth?

The chronic kidney disease market covered in this report is segmented –

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theChronic Kidney Disease Market?# Market?

North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Chronic Kidney Disease Industry?

The rising trend in the chronic kidney disease market is product innovation. A good example of competitors in this market developing ground-breaking products to solidify their market share is Bayer, a German company specializing in biotechnology and pharmaceuticals. In August 2022, Bayer launched a pioneering medication named Kerendia (finerenone), designed to alleviate the progression of chronic kidney disease in individuals suffering from diabetes. This medication is a unique class of non-steroidal, selective mineralocorticoid receptor antagonist, differentiating from existing treatments. Its core function is to obstruct an overly active mineralocorticoid receptor (MR), a key factor in the advancement of CKD and cardiovascular damage.

View the full report here:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

What Are the Key Elements That Define the Chronic Kidney Disease Market?

Chronic kidney disease is characterized by the inability of damaged kidneys to efficiently filter blood, resulting in excess fluid and blood waste in the body, potentially leading to health problems. It is commonly caused by diabetes, high blood pressure, and obesity. It requires careful, ongoing management and has the potential to proceed to end-stage renal failure requiring dialysis or transplant.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11969

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theChronic Kidney Disease Market?

The escalating incidence of kidney disease is projected to fuel the expansion of the chronic kidney disease market in the future. This refers to a set of disorders that impact the kidneys’ functionality and structure. Medicine for kidney disease aims to regulate patients’ blood pressure and reduce protein loss, thereby slowing kidney decay, treating symptoms, and preventing complications. For instance, data from July 2022 by the Centers for Disease Control and Prevention, a US-based national public health organization, stated that kidney disease touched around 15% or 37 million individuals in the US. Thus, the escalating incidence of kidney disease is propelling the growth of the chronic kidney disease market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

#How Does the Projected Chronic Kidney Disease Market Growth Compare Over the Forecast Period?

The market size of chronic kidney disease has seen robust growth in the past few years. The market, which was valued at $70.65 billion in 2024, is expected to upscale to $75.09 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.3%. Factors that have contributed to the historical growth trend comprise the prevalence of hypertension and diabetes, an aging population, unhealthy lifestyles, healthcare access disparities, and advancements in medical science.

Predictions indicate a robust expansion in the chronic kidney disease market in the coming years, with an estimation to reach a market value of $95.85 billion in 2029, boasting a compound annual growth rate (CAGR) of 6.3%. This anticipated advancement during the forecast period can be credited to factors such as a concentrated healthcare policy, the evolution of precision medicine, increasing rates of obesity, the rise of chronic diseases, and enhanced access to healthcare. The forecast period is also likely to witness significant trends like early detection initiatives, the incorporation of telemedicine and remote patient monitoring, programs fostering patient empowerment, community-oriented care strategies, and the implementation of nutritional therapy.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11969

What Are the Current Market Growth and Trends in theChronic Kidney Disease Market That Industry Players Should Watch?

One significant trend gaining traction in the chronic kidney disease market is product innovations. Companies in this industry are creating novel products to maintain their market dominance. For instance, Bayer, a biotechnology and pharmaceutical firm based in Germany, introduced the inventive medication Kerendia (finerenone) in August 2022. This medication aims to slow the progression of chronic kidney disease in individuals with diabetes. As a first-in-class non-steroidal, selective mineralocorticoid receptor antagonist, it differs from current treatments as it can block the overactivation of the mineralocorticoid receptor (MR), a factor that contributes to the progression of CKD and cardiovascular damage.

What Are the Major Market Players Making an Impact on theChronic Kidney Disease Market Growth?

Major companies operating in the chronic kidney disease market include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

How Are the Key Segments of the Chronic Kidney Disease Market Driving Opportunities and Innovations?

The chronic kidney disease market covered in this report is segmented –

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theChronic Kidney Disease Market?# Market Expansion?

North America was the largest region in the chronic kidney disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Chronic Kidney Disease Maret 2025, By The Business Research Company:

Styrene Butadiene Rubber (SBR) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/styrene-butadiene-rubber-sbr-global-market-report

Ethylene Propylene (EPDM) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ethylene-propylene-epdm-global-market-report

Polymer Biomaterial Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/polymer-biomaterial-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: